MEREO BIOPHARMA GROUP PLC (MREO) Operating cash flow 2022–2025
MEREO BIOPHARMA GROUP PLC (MREO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$31.0MFY2025 · since FY2022: -$48.8M → -$31.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.0M | +5.7% |
| FY2024 | -$32.8M | -55.4% |
| FY2023 | -$21.1M | +56.7% |
| FY2022 | -$48.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice